PacaƱa, Emmalou S.

HRN: 14-63-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
AMPICILLIN 1GM (VIAL)
05/29/2022
05/30/2022
IV
2g
Q6
Prom X16hrs
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: